Clinical Trial: Valproic AcId for Traumatic BRAin INjury Trial

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166393) titled 'Valproic AcId for Traumatic BRAin INjury Trial' on Sept. 03.

Brief Summary: The long-term goal of the clinical trial is to develop effective, safe, and easily administered life-saving treatments for patients with moderate to severe traumatic brain injury (TBI).

Patients with moderate to severe TBI will randomly receive either:

1. Standard of care treatment and normal saline

2. Standard of care treatment and one dose of valproic acid (VPA) at a lower dose or a higher dose

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Moderate Traumatic Brain Injury (TBI) Severe Traumatic Brain Injury

Intervention: DRUG: ...